Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 329 | 2024 | 12807 | 8.990 |
Why?
|
Genetic Predisposition to Disease | 365 | 2025 | 18071 | 8.000 |
Why?
|
Polymorphism, Single Nucleotide | 402 | 2024 | 16047 | 7.330 |
Why?
|
Breast Neoplasms | 184 | 2025 | 21056 | 4.640 |
Why?
|
Models, Genetic | 59 | 2021 | 3448 | 3.940 |
Why?
|
Case-Control Studies | 258 | 2024 | 22222 | 2.970 |
Why?
|
Genetic Variation | 78 | 2024 | 6610 | 2.950 |
Why?
|
Prostatic Neoplasms | 98 | 2023 | 11083 | 2.900 |
Why?
|
Genetic Loci | 60 | 2024 | 2631 | 2.850 |
Why?
|
Pancreatic Neoplasms | 55 | 2024 | 5444 | 2.590 |
Why?
|
Genotype | 171 | 2024 | 13024 | 2.530 |
Why?
|
Multifactorial Inheritance | 30 | 2024 | 1425 | 2.410 |
Why?
|
Quantitative Trait Loci | 45 | 2023 | 2140 | 2.370 |
Why?
|
Linkage Disequilibrium | 55 | 2022 | 1997 | 1.910 |
Why?
|
Mendelian Randomization Analysis | 30 | 2023 | 1044 | 1.770 |
Why?
|
Quantitative Trait, Heritable | 10 | 2020 | 541 | 1.660 |
Why?
|
Risk Factors | 235 | 2025 | 74836 | 1.570 |
Why?
|
Chromosome Mapping | 39 | 2022 | 4618 | 1.460 |
Why?
|
Alleles | 65 | 2023 | 6897 | 1.370 |
Why?
|
Genome, Human | 42 | 2022 | 4448 | 1.330 |
Why?
|
Humans | 690 | 2025 | 765956 | 1.310 |
Why?
|
Female | 464 | 2025 | 396101 | 1.250 |
Why?
|
Vitamin D | 22 | 2020 | 3272 | 1.240 |
Why?
|
Haplotypes | 36 | 2022 | 2728 | 1.210 |
Why?
|
Glaucoma, Open-Angle | 13 | 2024 | 742 | 1.210 |
Why?
|
Receptors, Estrogen | 29 | 2023 | 2242 | 1.190 |
Why?
|
Models, Statistical | 21 | 2020 | 5089 | 1.180 |
Why?
|
Endometrial Neoplasms | 15 | 2023 | 1378 | 1.170 |
Why?
|
Diabetes Mellitus, Type 2 | 38 | 2023 | 12240 | 1.140 |
Why?
|
Germ-Line Mutation | 17 | 2025 | 1884 | 1.110 |
Why?
|
Genes | 6 | 2015 | 1825 | 1.100 |
Why?
|
Middle Aged | 293 | 2025 | 223004 | 1.040 |
Why?
|
Risk | 61 | 2023 | 9591 | 1.020 |
Why?
|
Body Mass Index | 54 | 2023 | 13039 | 1.020 |
Why?
|
Gene Frequency | 38 | 2024 | 3624 | 1.010 |
Why?
|
Telomere | 11 | 2019 | 943 | 0.990 |
Why?
|
Environment | 8 | 2015 | 1114 | 0.970 |
Why?
|
Odds Ratio | 62 | 2024 | 9649 | 0.950 |
Why?
|
ABO Blood-Group System | 11 | 2023 | 380 | 0.950 |
Why?
|
Genetic Markers | 19 | 2018 | 2601 | 0.950 |
Why?
|
Ovarian Neoplasms | 18 | 2023 | 4900 | 0.920 |
Why?
|
BRCA1 Protein | 12 | 2023 | 1153 | 0.900 |
Why?
|
Aged | 213 | 2025 | 171114 | 0.850 |
Why?
|
Male | 324 | 2025 | 363691 | 0.850 |
Why?
|
Smoking | 30 | 2021 | 9081 | 0.830 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2023 | 1758 | 0.830 |
Why?
|
Genomics | 23 | 2022 | 5929 | 0.820 |
Why?
|
Fatty Acid Desaturases | 4 | 2018 | 102 | 0.810 |
Why?
|
Risk Assessment | 60 | 2024 | 24283 | 0.800 |
Why?
|
Genetic Association Studies | 28 | 2021 | 2741 | 0.800 |
Why?
|
Body Height | 11 | 2022 | 1562 | 0.790 |
Why?
|
Computer Simulation | 18 | 2021 | 6255 | 0.760 |
Why?
|
Menarche | 9 | 2024 | 532 | 0.740 |
Why?
|
Venous Thromboembolism | 11 | 2024 | 1882 | 0.740 |
Why?
|
Genetic Testing | 17 | 2023 | 3595 | 0.740 |
Why?
|
Germ Cells | 7 | 2023 | 647 | 0.730 |
Why?
|
Insulin-Like Growth Factor I | 12 | 2017 | 1936 | 0.720 |
Why?
|
Phenotype | 58 | 2022 | 16721 | 0.700 |
Why?
|
Europe | 23 | 2022 | 3423 | 0.700 |
Why?
|
Nurses | 15 | 2019 | 2505 | 0.700 |
Why?
|
Intraocular Pressure | 10 | 2024 | 1304 | 0.680 |
Why?
|
Adult | 188 | 2025 | 223038 | 0.680 |
Why?
|
Molecular Epidemiology | 8 | 2019 | 471 | 0.680 |
Why?
|
Prospective Studies | 89 | 2025 | 54806 | 0.670 |
Why?
|
Colorectal Neoplasms | 26 | 2020 | 6942 | 0.670 |
Why?
|
Chromosomes, Human, Pair 5 | 9 | 2017 | 386 | 0.660 |
Why?
|
Adenocarcinoma | 16 | 2021 | 6364 | 0.660 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 4 | 2018 | 93 | 0.640 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 9 | 2016 | 416 | 0.640 |
Why?
|
Principal Component Analysis | 9 | 2015 | 951 | 0.620 |
Why?
|
Metabolomics | 8 | 2023 | 1668 | 0.620 |
Why?
|
Inheritance Patterns | 7 | 2019 | 345 | 0.620 |
Why?
|
Multivariate Analysis | 20 | 2021 | 12057 | 0.620 |
Why?
|
Skin Neoplasms | 22 | 2020 | 5849 | 0.610 |
Why?
|
Metabolome | 5 | 2023 | 1005 | 0.610 |
Why?
|
Telomerase | 9 | 2018 | 749 | 0.610 |
Why?
|
Disease | 7 | 2017 | 676 | 0.600 |
Why?
|
BRCA2 Protein | 7 | 2023 | 800 | 0.600 |
Why?
|
Chromosomes, Human, Pair 8 | 8 | 2018 | 451 | 0.580 |
Why?
|
Cohort Studies | 84 | 2022 | 41647 | 0.580 |
Why?
|
Meta-Analysis as Topic | 15 | 2017 | 1370 | 0.570 |
Why?
|
Genetics, Population | 8 | 2021 | 943 | 0.560 |
Why?
|
Postmenopause | 15 | 2024 | 2515 | 0.560 |
Why?
|
Carotenoids | 5 | 2021 | 619 | 0.560 |
Why?
|
Polymorphism, Genetic | 20 | 2017 | 4247 | 0.550 |
Why?
|
Computational Biology | 12 | 2021 | 3559 | 0.550 |
Why?
|
Carcinoma, Squamous Cell | 12 | 2020 | 4044 | 0.540 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2018 | 223 | 0.540 |
Why?
|
Genetic Diseases, Inborn | 5 | 2016 | 605 | 0.540 |
Why?
|
Vital Capacity | 2 | 2017 | 995 | 0.540 |
Why?
|
Neoplasms | 27 | 2025 | 22340 | 0.520 |
Why?
|
Penetrance | 6 | 2023 | 388 | 0.520 |
Why?
|
Receptors, Progesterone | 11 | 2022 | 1153 | 0.520 |
Why?
|
Life Style | 7 | 2025 | 3926 | 0.500 |
Why?
|
Lipid Metabolism | 4 | 2020 | 1892 | 0.500 |
Why?
|
Genetic Linkage | 9 | 2013 | 2341 | 0.490 |
Why?
|
Heredity | 2 | 2013 | 149 | 0.490 |
Why?
|
Gonadal Steroid Hormones | 11 | 2017 | 705 | 0.480 |
Why?
|
Forced Expiratory Volume | 3 | 2017 | 1828 | 0.480 |
Why?
|
Menopause | 14 | 2023 | 1659 | 0.480 |
Why?
|
Factor XII | 1 | 2014 | 20 | 0.480 |
Why?
|
Bees | 2 | 2014 | 48 | 0.470 |
Why?
|
Thrombosis | 6 | 2023 | 2949 | 0.470 |
Why?
|
Genetic Pleiotropy | 6 | 2022 | 182 | 0.470 |
Why?
|
Tobacco Use Disorder | 7 | 2019 | 708 | 0.470 |
Why?
|
Carcinoma, Basal Cell | 8 | 2019 | 566 | 0.470 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2023 | 485 | 0.460 |
Why?
|
Factor XI | 1 | 2014 | 40 | 0.460 |
Why?
|
Toll-Like Receptor 4 | 4 | 2012 | 586 | 0.460 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 786 | 0.450 |
Why?
|
Fatty Acids | 3 | 2018 | 1806 | 0.440 |
Why?
|
Metabolic Networks and Pathways | 8 | 2018 | 798 | 0.440 |
Why?
|
Likelihood Functions | 12 | 2023 | 993 | 0.430 |
Why?
|
Alcohol Drinking | 11 | 2024 | 4040 | 0.430 |
Why?
|
Receptors, Somatostatin | 2 | 2014 | 138 | 0.430 |
Why?
|
Molecular Sequence Annotation | 7 | 2021 | 523 | 0.420 |
Why?
|
Gene Expression | 13 | 2023 | 7584 | 0.420 |
Why?
|
Adiposity | 7 | 2023 | 1890 | 0.420 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2019 | 3655 | 0.420 |
Why?
|
Toll-Like Receptor 6 | 2 | 2010 | 29 | 0.420 |
Why?
|
Chromosomes, Human, Pair 2 | 7 | 2021 | 313 | 0.420 |
Why?
|
Polycystic Ovary Syndrome | 4 | 2022 | 389 | 0.420 |
Why?
|
Genetics, Medical | 3 | 2021 | 334 | 0.420 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 3 | 2010 | 58 | 0.410 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 207 | 0.410 |
Why?
|
Mammography | 12 | 2022 | 2423 | 0.400 |
Why?
|
Logistic Models | 37 | 2021 | 13266 | 0.400 |
Why?
|
Ischemic Attack, Transient | 2 | 2014 | 870 | 0.400 |
Why?
|
Receptors, Nicotinic | 6 | 2015 | 494 | 0.390 |
Why?
|
Carcinoma, Lobular | 4 | 2021 | 471 | 0.390 |
Why?
|
Diabetes Complications | 3 | 2020 | 1316 | 0.390 |
Why?
|
Premenopause | 8 | 2021 | 1037 | 0.390 |
Why?
|
Bayes Theorem | 12 | 2023 | 2354 | 0.390 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2016 | 3796 | 0.380 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2016 | 640 | 0.380 |
Why?
|
United States | 66 | 2024 | 72898 | 0.380 |
Why?
|
Aged, 80 and over | 52 | 2022 | 59488 | 0.370 |
Why?
|
Sample Size | 11 | 2022 | 845 | 0.370 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8611 | 0.360 |
Why?
|
Reproduction | 5 | 2023 | 641 | 0.360 |
Why?
|
Signal Transduction | 23 | 2021 | 23600 | 0.360 |
Why?
|
Databases, Genetic | 9 | 2020 | 1751 | 0.360 |
Why?
|
Research Design | 9 | 2022 | 6208 | 0.350 |
Why?
|
Waist-Hip Ratio | 5 | 2016 | 520 | 0.350 |
Why?
|
Proportional Hazards Models | 25 | 2025 | 12509 | 0.350 |
Why?
|
Neoplasm Proteins | 9 | 2019 | 3596 | 0.350 |
Why?
|
Epigenomics | 1 | 2016 | 959 | 0.350 |
Why?
|
DNA-Binding Proteins | 15 | 2023 | 9601 | 0.350 |
Why?
|
Birth Order | 2 | 2016 | 93 | 0.350 |
Why?
|
Estrogen Replacement Therapy | 7 | 2024 | 1206 | 0.340 |
Why?
|
von Willebrand Factor | 1 | 2014 | 676 | 0.340 |
Why?
|
National Cancer Institute (U.S.) | 6 | 2015 | 299 | 0.340 |
Why?
|
Carcinoma, Ductal, Breast | 5 | 2025 | 1083 | 0.340 |
Why?
|
Chromosomes, Human | 5 | 2017 | 437 | 0.340 |
Why?
|
Chromosomes, Human, Pair 12 | 4 | 2018 | 430 | 0.330 |
Why?
|
Follow-Up Studies | 40 | 2024 | 39194 | 0.330 |
Why?
|
Obesity | 22 | 2023 | 13075 | 0.330 |
Why?
|
Age of Onset | 8 | 2025 | 3343 | 0.330 |
Why?
|
Mutation | 18 | 2023 | 30196 | 0.330 |
Why?
|
Receptors, Leptin | 4 | 2023 | 355 | 0.330 |
Why?
|
Exercise | 5 | 2019 | 5937 | 0.330 |
Why?
|
Republic of Korea | 2 | 2023 | 588 | 0.330 |
Why?
|
Statistics as Topic | 3 | 2010 | 2352 | 0.330 |
Why?
|
Genetic Research | 3 | 2011 | 173 | 0.320 |
Why?
|
Lung Neoplasms | 20 | 2019 | 13451 | 0.320 |
Why?
|
Leptin | 4 | 2023 | 1596 | 0.320 |
Why?
|
Arylamine N-Acetyltransferase | 2 | 2023 | 87 | 0.320 |
Why?
|
Carcinoma | 5 | 2012 | 2312 | 0.320 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 5 | 2019 | 220 | 0.320 |
Why?
|
Siblings | 5 | 2013 | 828 | 0.310 |
Why?
|
Linear Models | 13 | 2021 | 5876 | 0.310 |
Why?
|
Environmental Exposure | 6 | 2020 | 4543 | 0.310 |
Why?
|
Leukocytes | 6 | 2019 | 2027 | 0.310 |
Why?
|
Light | 2 | 2014 | 1364 | 0.310 |
Why?
|
Esophageal Neoplasms | 3 | 2014 | 1661 | 0.310 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2022 | 1376 | 0.310 |
Why?
|
Mammary Glands, Human | 3 | 2015 | 199 | 0.300 |
Why?
|
DNA Methylation | 5 | 2020 | 4424 | 0.300 |
Why?
|
Urinary Bladder Neoplasms | 6 | 2023 | 2176 | 0.300 |
Why?
|
Anti-Mullerian Hormone | 2 | 2022 | 420 | 0.290 |
Why?
|
Puberty | 2 | 2024 | 491 | 0.290 |
Why?
|
Regression Analysis | 10 | 2018 | 6321 | 0.280 |
Why?
|
Family | 5 | 2018 | 3209 | 0.280 |
Why?
|
Nerve Tissue Proteins | 10 | 2019 | 4392 | 0.280 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1470 | 0.280 |
Why?
|
Disease Susceptibility | 11 | 2020 | 1789 | 0.280 |
Why?
|
Low Tension Glaucoma | 2 | 2024 | 24 | 0.270 |
Why?
|
Cues | 2 | 2014 | 877 | 0.270 |
Why?
|
Estrone | 5 | 2021 | 234 | 0.270 |
Why?
|
Hormones | 3 | 2018 | 863 | 0.270 |
Why?
|
Melanoma | 9 | 2020 | 5719 | 0.270 |
Why?
|
Sequence Deletion | 3 | 2021 | 1495 | 0.260 |
Why?
|
Gallstones | 2 | 2021 | 285 | 0.260 |
Why?
|
Chromosomes, Human, Pair 15 | 4 | 2011 | 360 | 0.260 |
Why?
|
Prolactin | 3 | 2024 | 625 | 0.260 |
Why?
|
Aromatase | 4 | 2012 | 147 | 0.260 |
Why?
|
Gene Expression Regulation | 8 | 2021 | 11888 | 0.260 |
Why?
|
Heterozygote | 9 | 2023 | 2794 | 0.260 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15651 | 0.250 |
Why?
|
Blood Platelets | 5 | 2023 | 2464 | 0.250 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 583 | 0.250 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2020 | 792 | 0.250 |
Why?
|
Chromosomes, Human, Pair 3 | 3 | 2020 | 323 | 0.250 |
Why?
|
Endometriosis | 3 | 2023 | 870 | 0.250 |
Why?
|
Area Under Curve | 4 | 2015 | 1638 | 0.250 |
Why?
|
Probability | 5 | 2021 | 2475 | 0.240 |
Why?
|
Vitamin A | 3 | 2013 | 610 | 0.240 |
Why?
|
Prognosis | 32 | 2021 | 29921 | 0.240 |
Why?
|
Gene Expression Profiling | 11 | 2020 | 9524 | 0.240 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 368 | 0.240 |
Why?
|
Estrogen Receptor beta | 4 | 2011 | 171 | 0.240 |
Why?
|
Receptor, Melanocortin, Type 1 | 3 | 2018 | 76 | 0.240 |
Why?
|
Triglycerides | 4 | 2020 | 2441 | 0.230 |
Why?
|
Early Detection of Cancer | 5 | 2022 | 3236 | 0.230 |
Why?
|
Diet | 15 | 2022 | 8086 | 0.230 |
Why?
|
ROC Curve | 7 | 2023 | 3620 | 0.230 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2024 | 163 | 0.230 |
Why?
|
Sensitivity and Specificity | 6 | 2014 | 14652 | 0.230 |
Why?
|
Rh Isoimmunization | 1 | 2004 | 23 | 0.230 |
Why?
|
Sex Hormone-Binding Globulin | 5 | 2014 | 558 | 0.230 |
Why?
|
Age Factors | 19 | 2019 | 18380 | 0.220 |
Why?
|
Skin Pigmentation | 3 | 2013 | 279 | 0.220 |
Why?
|
Incidence | 17 | 2023 | 21480 | 0.220 |
Why?
|
Sequence Analysis, DNA | 7 | 2021 | 4772 | 0.220 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 3 | 2010 | 125 | 0.220 |
Why?
|
Breast | 6 | 2022 | 1946 | 0.220 |
Why?
|
DNA Repair | 5 | 2015 | 2048 | 0.220 |
Why?
|
Chromosomes, Human, Pair 11 | 3 | 2019 | 412 | 0.220 |
Why?
|
Australia | 5 | 2014 | 1258 | 0.220 |
Why?
|
Membrane Proteins | 11 | 2023 | 7851 | 0.220 |
Why?
|
Alopecia | 2 | 2018 | 414 | 0.220 |
Why?
|
Receptors, Androgen | 5 | 2014 | 1088 | 0.210 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2009 | 532 | 0.210 |
Why?
|
Artifacts | 2 | 2011 | 1893 | 0.210 |
Why?
|
Homozygote | 5 | 2015 | 1775 | 0.210 |
Why?
|
False Positive Reactions | 5 | 2021 | 955 | 0.210 |
Why?
|
Pedigree | 5 | 2019 | 4526 | 0.210 |
Why?
|
Algorithms | 16 | 2023 | 14071 | 0.210 |
Why?
|
Blood Pressure Determination | 2 | 2003 | 647 | 0.210 |
Why?
|
Nevus, Pigmented | 2 | 2018 | 227 | 0.210 |
Why?
|
Diabetic Angiopathies | 2 | 2018 | 805 | 0.210 |
Why?
|
Progesterone | 3 | 2021 | 752 | 0.210 |
Why?
|
DNA Copy Number Variations | 3 | 2022 | 2045 | 0.210 |
Why?
|
Fertility | 3 | 2023 | 768 | 0.210 |
Why?
|
Vitamin D Deficiency | 4 | 2020 | 1348 | 0.200 |
Why?
|
Arterial Occlusive Diseases | 2 | 2017 | 729 | 0.200 |
Why?
|
Estrogens | 6 | 2022 | 1529 | 0.200 |
Why?
|
Glycoproteins | 1 | 2010 | 2195 | 0.200 |
Why?
|
Chromosomes, Human, Pair 7 | 3 | 2019 | 311 | 0.200 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2016 | 191 | 0.200 |
Why?
|
Feeding Behavior | 6 | 2020 | 3211 | 0.200 |
Why?
|
Fenofibrate | 2 | 2020 | 87 | 0.200 |
Why?
|
Lymphoma, B-Cell | 3 | 2020 | 943 | 0.200 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2025 | 920 | 0.200 |
Why?
|
Homocysteine | 4 | 2015 | 638 | 0.200 |
Why?
|
Parity | 3 | 2016 | 931 | 0.200 |
Why?
|
Arthritis, Rheumatoid | 3 | 2012 | 3733 | 0.200 |
Why?
|
Multigene Family | 4 | 2017 | 1080 | 0.200 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 3 | 2013 | 173 | 0.190 |
Why?
|
Software | 9 | 2017 | 4462 | 0.190 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2016 | 488 | 0.190 |
Why?
|
Hormone Replacement Therapy | 3 | 2022 | 753 | 0.190 |
Why?
|
Epidemiologic Studies | 3 | 2016 | 677 | 0.190 |
Why?
|
Validation Studies as Topic | 2 | 2020 | 162 | 0.190 |
Why?
|
Adiponectin | 4 | 2023 | 1119 | 0.190 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2021 | 28 | 0.190 |
Why?
|
Biometry | 1 | 2004 | 571 | 0.190 |
Why?
|
Depression | 7 | 2023 | 8230 | 0.190 |
Why?
|
Ovary | 3 | 2021 | 956 | 0.190 |
Why?
|
Pregnanediol | 1 | 2021 | 18 | 0.190 |
Why?
|
Smoking Cessation | 4 | 2015 | 2084 | 0.180 |
Why?
|
Medical History Taking | 3 | 2021 | 777 | 0.180 |
Why?
|
Promoter Regions, Genetic | 10 | 2021 | 5786 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2017 | 1646 | 0.180 |
Why?
|
Colonic Neoplasms | 4 | 2020 | 2531 | 0.180 |
Why?
|
Sex Factors | 11 | 2020 | 10602 | 0.180 |
Why?
|
Dietary Fats | 5 | 2019 | 2002 | 0.180 |
Why?
|
Cation Transport Proteins | 1 | 2023 | 325 | 0.180 |
Why?
|
Weight Loss | 2 | 2024 | 2710 | 0.180 |
Why?
|
Cholesterol, HDL | 4 | 2022 | 1811 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 117 | 0.180 |
Why?
|
Models, Theoretical | 5 | 2021 | 3564 | 0.180 |
Why?
|
Random Allocation | 3 | 2018 | 2395 | 0.180 |
Why?
|
Family Health | 3 | 2021 | 1253 | 0.170 |
Why?
|
Receptor, Melanocortin, Type 4 | 3 | 2015 | 132 | 0.170 |
Why?
|
Carcinogens, Environmental | 1 | 2020 | 70 | 0.170 |
Why?
|
Lysophosphatidylcholines | 1 | 2020 | 77 | 0.170 |
Why?
|
Aging | 7 | 2023 | 8731 | 0.170 |
Why?
|
Fibrinolytic Agents | 3 | 2016 | 2080 | 0.170 |
Why?
|
Mosaicism | 2 | 2015 | 481 | 0.170 |
Why?
|
Vesicular Transport Proteins | 3 | 2020 | 376 | 0.170 |
Why?
|
Pseudouridine | 1 | 2020 | 19 | 0.170 |
Why?
|
Hair Color | 3 | 2009 | 132 | 0.170 |
Why?
|
Sphingomyelins | 1 | 2020 | 102 | 0.170 |
Why?
|
Fanconi Anemia Complementation Group C Protein | 1 | 2019 | 21 | 0.170 |
Why?
|
Proteins | 9 | 2018 | 5995 | 0.170 |
Why?
|
Tricarboxylic Acids | 2 | 2018 | 26 | 0.170 |
Why?
|
Major Histocompatibility Complex | 2 | 2015 | 879 | 0.170 |
Why?
|
Body Weight | 5 | 2024 | 4622 | 0.170 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2011 | 285 | 0.170 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2011 | 276 | 0.160 |
Why?
|
Membrane Glycoproteins | 4 | 2015 | 3690 | 0.160 |
Why?
|
Helicobacter pylori | 1 | 2023 | 380 | 0.160 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2018 | 1365 | 0.160 |
Why?
|
Coronary Disease | 3 | 2015 | 5912 | 0.160 |
Why?
|
Selenium | 2 | 2014 | 419 | 0.160 |
Why?
|
Helicobacter Infections | 1 | 2023 | 390 | 0.160 |
Why?
|
Cerebral Hemorrhage | 3 | 2016 | 2648 | 0.160 |
Why?
|
Taste Perception | 1 | 2019 | 38 | 0.160 |
Why?
|
Cooperative Behavior | 6 | 2016 | 1509 | 0.160 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2014 | 350 | 0.160 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2428 | 0.160 |
Why?
|
Radon | 1 | 2020 | 90 | 0.160 |
Why?
|
Apolipoproteins E | 2 | 2019 | 1458 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2023 | 2899 | 0.160 |
Why?
|
Sex Characteristics | 7 | 2022 | 2643 | 0.160 |
Why?
|
Ceramides | 1 | 2020 | 201 | 0.160 |
Why?
|
Internationality | 2 | 2022 | 1007 | 0.160 |
Why?
|
Kidney Neoplasms | 5 | 2019 | 4274 | 0.160 |
Why?
|
Carrier Proteins | 2 | 2018 | 4913 | 0.160 |
Why?
|
Gene Regulatory Networks | 5 | 2020 | 1749 | 0.160 |
Why?
|
Survival Analysis | 11 | 2021 | 10070 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 3 | 2019 | 3181 | 0.150 |
Why?
|
Phosphatidylcholines | 1 | 2020 | 403 | 0.150 |
Why?
|
PPAR alpha | 1 | 2020 | 176 | 0.150 |
Why?
|
Twin Studies as Topic | 1 | 2018 | 103 | 0.150 |
Why?
|
Kallikreins | 2 | 2011 | 220 | 0.150 |
Why?
|
Microarray Analysis | 2 | 2019 | 752 | 0.150 |
Why?
|
Polymerase Chain Reaction | 6 | 2016 | 6069 | 0.150 |
Why?
|
Nevus | 1 | 2020 | 205 | 0.150 |
Why?
|
Blood Pressure | 4 | 2017 | 8532 | 0.150 |
Why?
|
Epistasis, Genetic | 2 | 2011 | 353 | 0.150 |
Why?
|
Particulate Matter | 3 | 2020 | 2624 | 0.150 |
Why?
|
Polyps | 1 | 2020 | 200 | 0.150 |
Why?
|
Schizophrenia | 4 | 2019 | 6971 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2014 | 416 | 0.150 |
Why?
|
Testosterone | 4 | 2018 | 2494 | 0.150 |
Why?
|
Arylalkylamine N-Acetyltransferase | 1 | 2017 | 13 | 0.140 |
Why?
|
Reproducibility of Results | 17 | 2021 | 20125 | 0.140 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 64 | 0.140 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 2016 | 127 | 0.140 |
Why?
|
Causality | 5 | 2023 | 1248 | 0.140 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 77 | 0.140 |
Why?
|
Diabetes Mellitus | 5 | 2020 | 5891 | 0.140 |
Why?
|
Vitamin B 12 | 3 | 2009 | 532 | 0.140 |
Why?
|
alpha-Linolenic Acid | 2 | 2009 | 145 | 0.140 |
Why?
|
Leiomyoma | 1 | 2022 | 643 | 0.140 |
Why?
|
Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
Genetic Heterogeneity | 5 | 2018 | 735 | 0.140 |
Why?
|
Oncogenes | 1 | 2023 | 1235 | 0.140 |
Why?
|
Asparagus Plant | 1 | 2016 | 4 | 0.140 |
Why?
|
Jews | 1 | 2019 | 357 | 0.140 |
Why?
|
Neoplasm Staging | 13 | 2021 | 11206 | 0.140 |
Why?
|
Women's Health | 5 | 2016 | 2084 | 0.140 |
Why?
|
Energy Intake | 4 | 2018 | 2140 | 0.140 |
Why?
|
Mutation, Missense | 4 | 2023 | 2589 | 0.140 |
Why?
|
Data Interpretation, Statistical | 5 | 2011 | 2686 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 122 | 0.140 |
Why?
|
Microtubule-Associated Proteins | 2 | 2023 | 1066 | 0.140 |
Why?
|
Menopause, Premature | 2 | 2021 | 124 | 0.140 |
Why?
|
Fecal Incontinence | 1 | 2019 | 245 | 0.140 |
Why?
|
Factor X | 1 | 2016 | 64 | 0.140 |
Why?
|
Receptor, Melanocortin, Type 2 | 1 | 2016 | 9 | 0.140 |
Why?
|
Keratin-13 | 1 | 2016 | 11 | 0.140 |
Why?
|
Circadian Clocks | 2 | 2020 | 168 | 0.140 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3110 | 0.130 |
Why?
|
Amino Acid Oxidoreductases | 1 | 2017 | 149 | 0.130 |
Why?
|
Reproductive Behavior | 1 | 2016 | 27 | 0.130 |
Why?
|
Heart Failure, Systolic | 1 | 2018 | 135 | 0.130 |
Why?
|
Longitudinal Studies | 9 | 2020 | 14749 | 0.130 |
Why?
|
Biotinidase | 1 | 2016 | 17 | 0.130 |
Why?
|
Gout | 2 | 2015 | 620 | 0.130 |
Why?
|
Dimethylnitrosamine | 3 | 1981 | 17 | 0.130 |
Why?
|
TRPM Cation Channels | 1 | 2017 | 139 | 0.130 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 1017 | 0.130 |
Why?
|
Tumor Burden | 2 | 2020 | 1885 | 0.130 |
Why?
|
Interleukin-6 | 4 | 2013 | 3222 | 0.130 |
Why?
|
beta-Carotene 15,15'-Monooxygenase | 2 | 2013 | 12 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 4 | 2016 | 4520 | 0.130 |
Why?
|
Stroke | 2 | 2017 | 9747 | 0.130 |
Why?
|
Young Adult | 25 | 2021 | 59886 | 0.130 |
Why?
|
Keratin-6 | 1 | 2015 | 15 | 0.130 |
Why?
|
Dairy Products | 1 | 2019 | 491 | 0.130 |
Why?
|
Cholesterol, LDL | 3 | 2022 | 2393 | 0.130 |
Why?
|
Prothrombin | 1 | 2016 | 193 | 0.130 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
Exfoliation Syndrome | 1 | 2017 | 113 | 0.130 |
Why?
|
Hemostasis | 2 | 2016 | 467 | 0.130 |
Why?
|
Keratin-5 | 1 | 2015 | 43 | 0.130 |
Why?
|
Chromosome Aberrations | 4 | 2015 | 1774 | 0.130 |
Why?
|
HLA Antigens | 3 | 2019 | 1339 | 0.130 |
Why?
|
Steroid Hydroxylases | 2 | 2013 | 93 | 0.130 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 109 | 0.130 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2016 | 40 | 0.130 |
Why?
|
Genome | 4 | 2012 | 1753 | 0.130 |
Why?
|
Waist Circumference | 3 | 2015 | 933 | 0.130 |
Why?
|
Aqueous Humor | 1 | 2016 | 152 | 0.130 |
Why?
|
Adolescent | 31 | 2024 | 88832 | 0.130 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2016 | 111 | 0.130 |
Why?
|
Serine Endopeptidases | 2 | 2023 | 1024 | 0.130 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3247 | 0.130 |
Why?
|
Epigenesis, Genetic | 4 | 2016 | 3819 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1014 | 0.130 |
Why?
|
Interferon Regulatory Factors | 3 | 2018 | 271 | 0.120 |
Why?
|
Membrane Transport Proteins | 4 | 2015 | 1028 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 95 | 0.120 |
Why?
|
OX40 Ligand | 1 | 2015 | 57 | 0.120 |
Why?
|
Keratinocytes | 2 | 2017 | 863 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2018 | 1657 | 0.120 |
Why?
|
Hypolipidemic Agents | 1 | 2020 | 608 | 0.120 |
Why?
|
Health Personnel | 6 | 2024 | 3390 | 0.120 |
Why?
|
Cytochrome P-450 CYP1A2 | 2 | 2014 | 68 | 0.120 |
Why?
|
Urinary Incontinence | 1 | 2019 | 491 | 0.120 |
Why?
|
Twins, Dizygotic | 1 | 2016 | 236 | 0.120 |
Why?
|
Urine | 1 | 2016 | 360 | 0.120 |
Why?
|
Point Mutation | 2 | 2017 | 1590 | 0.120 |
Why?
|
Caveolin 1 | 2 | 2014 | 255 | 0.120 |
Why?
|
Circadian Rhythm | 3 | 2017 | 2590 | 0.120 |
Why?
|
Inflammation | 7 | 2021 | 10850 | 0.120 |
Why?
|
Repressor Proteins | 4 | 2019 | 2968 | 0.120 |
Why?
|
Microsatellite Instability | 2 | 2017 | 728 | 0.120 |
Why?
|
Receptor, Melatonin, MT2 | 1 | 2015 | 84 | 0.120 |
Why?
|
Interleukin-15 | 1 | 2015 | 186 | 0.120 |
Why?
|
Dyssomnias | 1 | 2014 | 28 | 0.120 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 373 | 0.120 |
Why?
|
Cognition | 3 | 2019 | 7048 | 0.120 |
Why?
|
Meat | 2 | 2014 | 588 | 0.120 |
Why?
|
Blood Specimen Collection | 1 | 2016 | 238 | 0.120 |
Why?
|
Behavior, Animal | 2 | 2014 | 1865 | 0.120 |
Why?
|
Estrogen Receptor alpha | 3 | 2014 | 578 | 0.110 |
Why?
|
Acetyl Coenzyme A | 1 | 2014 | 74 | 0.110 |
Why?
|
Parents | 5 | 2020 | 3592 | 0.110 |
Why?
|
Olfaction Disorders | 1 | 2016 | 223 | 0.110 |
Why?
|
beta Catenin | 2 | 2013 | 1043 | 0.110 |
Why?
|
Adenoma | 2 | 2020 | 2152 | 0.110 |
Why?
|
Cyclin E | 1 | 2014 | 156 | 0.110 |
Why?
|
High Mobility Group Proteins | 2 | 2012 | 180 | 0.110 |
Why?
|
Agouti Signaling Protein | 2 | 2011 | 22 | 0.110 |
Why?
|
Aspirin | 2 | 2017 | 3134 | 0.110 |
Why?
|
Coronary Artery Disease | 5 | 2018 | 6546 | 0.110 |
Why?
|
Organ Size | 1 | 2019 | 2261 | 0.110 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 253 | 0.110 |
Why?
|
Caveolin 2 | 1 | 2013 | 25 | 0.110 |
Why?
|
Twins, Monozygotic | 1 | 2016 | 469 | 0.110 |
Why?
|
Apolipoprotein E2 | 1 | 2014 | 133 | 0.110 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2013 | 378 | 0.110 |
Why?
|
Testicular Neoplasms | 2 | 2017 | 786 | 0.110 |
Why?
|
Ocular Physiological Phenomena | 1 | 2014 | 67 | 0.110 |
Why?
|
Beverages | 1 | 2019 | 819 | 0.110 |
Why?
|
Spirometry | 1 | 2017 | 929 | 0.110 |
Why?
|
Functional Laterality | 1 | 2020 | 2243 | 0.110 |
Why?
|
Intestinal Neoplasms | 1 | 2016 | 313 | 0.110 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2018 | 1441 | 0.110 |
Why?
|
Receptor, Insulin | 1 | 2017 | 837 | 0.110 |
Why?
|
Lipids | 6 | 2022 | 3316 | 0.110 |
Why?
|
Casein Kinase II | 1 | 2014 | 120 | 0.110 |
Why?
|
Publishing | 2 | 2011 | 835 | 0.110 |
Why?
|
Domperidone | 1 | 2013 | 24 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1140 | 0.110 |
Why?
|
Genealogy and Heraldry | 1 | 2013 | 29 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 619 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2021 | 1051 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2021 | 729 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Enhancer Elements, Genetic | 3 | 2016 | 1365 | 0.110 |
Why?
|
Open Reading Frames | 1 | 2016 | 820 | 0.110 |
Why?
|
Chronic Disease | 5 | 2018 | 9347 | 0.110 |
Why?
|
Air Pollutants | 4 | 2020 | 2923 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2013 | 81 | 0.110 |
Why?
|
Phospholipase D | 1 | 2013 | 71 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2018 | 770 | 0.100 |
Why?
|
Prostate-Specific Antigen | 3 | 2012 | 2464 | 0.100 |
Why?
|
Calcium Signaling | 1 | 2017 | 733 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 3807 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3251 | 0.100 |
Why?
|
Iron | 1 | 2021 | 1816 | 0.100 |
Why?
|
Lod Score | 2 | 2003 | 598 | 0.100 |
Why?
|
Estradiol | 4 | 2014 | 1947 | 0.100 |
Why?
|
Myositis | 1 | 2015 | 270 | 0.100 |
Why?
|
Selenoproteins | 2 | 2014 | 216 | 0.100 |
Why?
|
Trichomonas Infections | 1 | 2012 | 41 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2016 | 4058 | 0.100 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2012 | 69 | 0.100 |
Why?
|
Bone Neoplasms | 3 | 2015 | 2567 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2020 | 869 | 0.100 |
Why?
|
Hodgkin Disease | 2 | 2011 | 1383 | 0.100 |
Why?
|
Blood Glucose | 5 | 2022 | 6425 | 0.100 |
Why?
|
Antibody Formation | 1 | 2017 | 1391 | 0.100 |
Why?
|
Perception | 2 | 2015 | 1205 | 0.100 |
Why?
|
Carbon | 2 | 2013 | 677 | 0.100 |
Why?
|
Homeostasis | 1 | 2023 | 3336 | 0.100 |
Why?
|
Hyperuricemia | 1 | 2015 | 221 | 0.100 |
Why?
|
Myocardial Infarction | 5 | 2016 | 11501 | 0.100 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 250 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 266 | 0.100 |
Why?
|
Diuretics | 1 | 2015 | 613 | 0.090 |
Why?
|
Confidence Intervals | 5 | 2012 | 2910 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2023 | 1608 | 0.090 |
Why?
|
Discriminant Analysis | 1 | 2012 | 222 | 0.090 |
Why?
|
Child | 20 | 2024 | 80563 | 0.090 |
Why?
|
Adipose Tissue | 6 | 2016 | 3312 | 0.090 |
Why?
|
Steroid 17-alpha-Hydroxylase | 2 | 2011 | 99 | 0.090 |
Why?
|
Genetic Phenomena | 1 | 2011 | 6 | 0.090 |
Why?
|
Nuclear Proteins | 5 | 2022 | 5783 | 0.090 |
Why?
|
Methionine | 2 | 2011 | 569 | 0.090 |
Why?
|
Norway | 3 | 2016 | 499 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2016 | 550 | 0.090 |
Why?
|
Models, Biological | 5 | 2019 | 9443 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3946 | 0.090 |
Why?
|
Estradiol Dehydrogenases | 1 | 2010 | 16 | 0.090 |
Why?
|
Costa Rica | 5 | 2009 | 186 | 0.090 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2012 | 320 | 0.090 |
Why?
|
Primary Ovarian Insufficiency | 3 | 2021 | 104 | 0.090 |
Why?
|
Cyclin D1 | 1 | 2013 | 449 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2014 | 6203 | 0.090 |
Why?
|
Pulmonary Embolism | 2 | 2018 | 2598 | 0.090 |
Why?
|
Glycine | 1 | 2014 | 672 | 0.090 |
Why?
|
CpG Islands | 3 | 2020 | 1207 | 0.090 |
Why?
|
Physical Chromosome Mapping | 1 | 2011 | 183 | 0.090 |
Why?
|
Behavior, Addictive | 1 | 2016 | 423 | 0.090 |
Why?
|
Ferritins | 1 | 2014 | 600 | 0.090 |
Why?
|
Osteosarcoma | 2 | 2015 | 909 | 0.090 |
Why?
|
Data Collection | 2 | 2018 | 3318 | 0.090 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
Hydro-Lyases | 1 | 2010 | 93 | 0.090 |
Why?
|
Calcium | 3 | 2023 | 5767 | 0.090 |
Why?
|
Laminin | 1 | 2012 | 404 | 0.090 |
Why?
|
Transcription Factors | 4 | 2017 | 12131 | 0.090 |
Why?
|
Drinking Behavior | 1 | 2011 | 101 | 0.090 |
Why?
|
Amide Synthases | 1 | 2010 | 14 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2014 | 710 | 0.090 |
Why?
|
Acyl-CoA Dehydrogenase | 1 | 2010 | 57 | 0.090 |
Why?
|
Pilot Projects | 3 | 2014 | 8733 | 0.090 |
Why?
|
Antiporters | 2 | 2009 | 275 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2268 | 0.090 |
Why?
|
Motivation | 2 | 2013 | 2018 | 0.090 |
Why?
|
Hypothalamus | 1 | 2015 | 993 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2014 | 459 | 0.090 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 2226 | 0.090 |
Why?
|
RNA | 2 | 2018 | 2717 | 0.090 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2017 | 538 | 0.080 |
Why?
|
Periodontitis | 1 | 2015 | 576 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2010 | 2878 | 0.080 |
Why?
|
China | 2 | 2013 | 2385 | 0.080 |
Why?
|
Neoplasm Invasiveness | 4 | 2021 | 3602 | 0.080 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 2023 | 282 | 0.080 |
Why?
|
Antigens, CD | 2 | 2017 | 4025 | 0.080 |
Why?
|
Neuroendocrine Tumors | 1 | 2016 | 654 | 0.080 |
Why?
|
Carcinoma in Situ | 1 | 2015 | 779 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 3 | 2016 | 2796 | 0.080 |
Why?
|
Prostatic Secretory Proteins | 1 | 2009 | 24 | 0.080 |
Why?
|
Dietary Carbohydrates | 2 | 2017 | 894 | 0.080 |
Why?
|
NF-kappa B | 2 | 2009 | 2485 | 0.080 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15398 | 0.080 |
Why?
|
Folic Acid | 3 | 2011 | 1339 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 634 | 0.080 |
Why?
|
Brain Diseases | 1 | 2018 | 1546 | 0.080 |
Why?
|
Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
Vitamin B Complex | 1 | 2011 | 299 | 0.080 |
Why?
|
Animals | 24 | 2024 | 168759 | 0.080 |
Why?
|
Nuclear Family | 2 | 2000 | 311 | 0.080 |
Why?
|
Air Pollution | 2 | 2020 | 2380 | 0.080 |
Why?
|
Registries | 5 | 2020 | 8297 | 0.080 |
Why?
|
Actins | 1 | 2016 | 2056 | 0.080 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 686 | 0.080 |
Why?
|
Quality Control | 4 | 2014 | 837 | 0.080 |
Why?
|
Genome, Mitochondrial | 1 | 2009 | 68 | 0.080 |
Why?
|
Oxo-Acid-Lyases | 1 | 2008 | 23 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2015 | 1801 | 0.080 |
Why?
|
Population Surveillance | 5 | 2019 | 2590 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2018 | 2880 | 0.080 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 137 | 0.080 |
Why?
|
Mass Screening | 2 | 2022 | 5445 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1624 | 0.080 |
Why?
|
Sunbathing | 1 | 2009 | 66 | 0.080 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2009 | 274 | 0.080 |
Why?
|
Multiple Sclerosis | 2 | 2015 | 3213 | 0.080 |
Why?
|
Disclosure | 2 | 2011 | 756 | 0.080 |
Why?
|
Bipolar Disorder | 2 | 2023 | 5128 | 0.080 |
Why?
|
Work Schedule Tolerance | 1 | 2012 | 554 | 0.070 |
Why?
|
DNA | 3 | 2019 | 7202 | 0.070 |
Why?
|
Interleukin-18 | 1 | 2010 | 251 | 0.070 |
Why?
|
Marriage | 1 | 2010 | 351 | 0.070 |
Why?
|
Fucosyltransferases | 1 | 2008 | 118 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2021 | 6499 | 0.070 |
Why?
|
Scavenger Receptors, Class A | 1 | 2008 | 51 | 0.070 |
Why?
|
Puberty, Delayed | 2 | 2024 | 124 | 0.070 |
Why?
|
Toll-Like Receptor 10 | 1 | 2007 | 12 | 0.070 |
Why?
|
Fats | 1 | 2008 | 99 | 0.070 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2014 | 1140 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1434 | 0.070 |
Why?
|
Epidemiologic Methods | 2 | 2010 | 1326 | 0.070 |
Why?
|
Time Factors | 11 | 2021 | 40065 | 0.070 |
Why?
|
Toll-Like Receptor 1 | 1 | 2007 | 48 | 0.070 |
Why?
|
E-Selectin | 1 | 2010 | 576 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2017 | 2115 | 0.070 |
Why?
|
One-Carbon Group Transferases | 1 | 2007 | 6 | 0.070 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1499 | 0.070 |
Why?
|
Puberty, Precocious | 2 | 2024 | 163 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1067 | 0.070 |
Why?
|
Insulin Resistance | 4 | 2017 | 3985 | 0.070 |
Why?
|
Receptors, Interleukin | 1 | 2008 | 243 | 0.070 |
Why?
|
Heart Rate | 2 | 2023 | 4203 | 0.070 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2015 | 857 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2009 | 594 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2892 | 0.070 |
Why?
|
Japan | 1 | 2011 | 1415 | 0.070 |
Why?
|
Antioxidants | 1 | 2015 | 1670 | 0.070 |
Why?
|
Checklist | 2 | 2011 | 848 | 0.070 |
Why?
|
Receptors, Interleukin-6 | 1 | 2008 | 226 | 0.070 |
Why?
|
Insulin | 4 | 2022 | 6599 | 0.070 |
Why?
|
Carnitine | 2 | 2018 | 253 | 0.070 |
Why?
|
Microfilament Proteins | 3 | 2019 | 1130 | 0.070 |
Why?
|
Vitamin E | 1 | 2011 | 869 | 0.070 |
Why?
|
Carotid Artery Diseases | 1 | 2013 | 874 | 0.070 |
Why?
|
Visual Fields | 1 | 2013 | 1063 | 0.070 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2007 | 85 | 0.070 |
Why?
|
Uric Acid | 1 | 2012 | 809 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2006 | 13 | 0.070 |
Why?
|
Caffeine | 1 | 2011 | 702 | 0.070 |
Why?
|
Glycemic Index | 1 | 2009 | 400 | 0.070 |
Why?
|
Cluster Analysis | 3 | 2021 | 2720 | 0.070 |
Why?
|
Receptors, Calcitriol | 1 | 2009 | 361 | 0.070 |
Why?
|
I-kappa B Proteins | 1 | 2007 | 209 | 0.070 |
Why?
|
MicroRNAs | 3 | 2018 | 3785 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1087 | 0.060 |
Why?
|
Lung | 3 | 2019 | 10033 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 7 | 2023 | 10383 | 0.060 |
Why?
|
Eating | 2 | 2013 | 1539 | 0.060 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 898 | 0.060 |
Why?
|
Trinucleotide Repeats | 3 | 2014 | 258 | 0.060 |
Why?
|
Biosynthetic Pathways | 1 | 2006 | 138 | 0.060 |
Why?
|
Warfarin | 1 | 2014 | 1494 | 0.060 |
Why?
|
Transcription Factor RelA | 1 | 2007 | 252 | 0.060 |
Why?
|
Immunity | 1 | 2012 | 1002 | 0.060 |
Why?
|
C-Reactive Protein | 3 | 2018 | 3850 | 0.060 |
Why?
|
Adipokines | 2 | 2023 | 308 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2016 | 856 | 0.060 |
Why?
|
Rad51 Recombinase | 2 | 2018 | 191 | 0.060 |
Why?
|
Introns | 3 | 2017 | 966 | 0.060 |
Why?
|
Steroids | 1 | 2010 | 933 | 0.060 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2593 | 0.060 |
Why?
|
Hypertension | 3 | 2019 | 8626 | 0.060 |
Why?
|
Selection, Genetic | 2 | 2023 | 878 | 0.060 |
Why?
|
Platelet Activation | 2 | 2023 | 645 | 0.060 |
Why?
|
Sperm Count | 1 | 2006 | 227 | 0.060 |
Why?
|
Indoles | 1 | 2013 | 1839 | 0.060 |
Why?
|
Epidemiology | 1 | 2007 | 279 | 0.060 |
Why?
|
Wnt Proteins | 2 | 2013 | 722 | 0.060 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2024 | 45 | 0.060 |
Why?
|
Choice Behavior | 1 | 2011 | 844 | 0.060 |
Why?
|
Cotinine | 2 | 2017 | 206 | 0.060 |
Why?
|
Anxiety Disorders | 1 | 2016 | 2736 | 0.060 |
Why?
|
Poisson Distribution | 1 | 2006 | 508 | 0.060 |
Why?
|
PPAR gamma | 1 | 2007 | 483 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2013 | 1393 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5189 | 0.060 |
Why?
|
Glaucoma | 1 | 2014 | 1194 | 0.060 |
Why?
|
Ozone | 2 | 2006 | 499 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2921 | 0.060 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1327 | 0.060 |
Why?
|
Brain Ischemia | 1 | 2017 | 3000 | 0.060 |
Why?
|
Mice | 12 | 2024 | 81818 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2024 | 1241 | 0.060 |
Why?
|
Pharmacogenetics | 2 | 2020 | 682 | 0.060 |
Why?
|
Acute Disease | 1 | 2014 | 7232 | 0.060 |
Why?
|
Celiac Disease | 1 | 2012 | 820 | 0.060 |
Why?
|
Body Size | 3 | 2011 | 459 | 0.060 |
Why?
|
Genomic Imprinting | 2 | 2017 | 326 | 0.060 |
Why?
|
Cholesterol | 2 | 2016 | 2898 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2005 | 370 | 0.060 |
Why?
|
Iceland | 2 | 2014 | 183 | 0.050 |
Why?
|
Self Report | 4 | 2018 | 3771 | 0.050 |
Why?
|
Interleukins | 1 | 2008 | 791 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2015 | 1927 | 0.050 |
Why?
|
Cell Line, Tumor | 6 | 2017 | 17075 | 0.050 |
Why?
|
Receptors, Adiponectin | 1 | 2023 | 82 | 0.050 |
Why?
|
Glutathione Peroxidase | 1 | 2004 | 256 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2247 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2005 | 491 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1915 | 0.050 |
Why?
|
Anxiety | 1 | 2018 | 4668 | 0.050 |
Why?
|
Survival Rate | 5 | 2017 | 12795 | 0.050 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2024 | 187 | 0.050 |
Why?
|
Cations | 1 | 2023 | 240 | 0.050 |
Why?
|
Health Surveys | 3 | 2020 | 4056 | 0.050 |
Why?
|
Matched-Pair Analysis | 2 | 2000 | 284 | 0.050 |
Why?
|
Binding Sites | 3 | 2017 | 6001 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3715 | 0.050 |
Why?
|
Pregnancy | 5 | 2020 | 30258 | 0.050 |
Why?
|
Crohn Disease | 1 | 2015 | 2283 | 0.050 |
Why?
|
Eczema | 1 | 2005 | 246 | 0.050 |
Why?
|
Longevity | 2 | 2021 | 1087 | 0.050 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2003 | 182 | 0.050 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 651 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2021 | 22331 | 0.050 |
Why?
|
Linoleic Acid | 2 | 2017 | 157 | 0.050 |
Why?
|
Disease Progression | 6 | 2016 | 13631 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13461 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2016 | 371 | 0.050 |
Why?
|
Dioxygenases | 2 | 2014 | 354 | 0.050 |
Why?
|
T-Box Domain Proteins | 2 | 2016 | 469 | 0.050 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2016 | 605 | 0.050 |
Why?
|
Cyclin T | 1 | 2021 | 19 | 0.050 |
Why?
|
Central Nervous System | 1 | 2008 | 1341 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2003 | 332 | 0.050 |
Why?
|
Selection Bias | 1 | 2023 | 361 | 0.050 |
Why?
|
Gene Dosage | 3 | 2010 | 1216 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2009 | 3513 | 0.050 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2013 | 152 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1884 | 0.050 |
Why?
|
Calcium Channels | 2 | 2017 | 622 | 0.050 |
Why?
|
Genes, BRCA1 | 1 | 2004 | 750 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2017 | 1077 | 0.050 |
Why?
|
Intention | 1 | 2024 | 346 | 0.040 |
Why?
|
Asthma | 1 | 2020 | 6270 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2018 | 569 | 0.040 |
Why?
|
Fragile X Mental Retardation Protein | 1 | 2021 | 114 | 0.040 |
Why?
|
Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2017 | 1892 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2017 | 12769 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2023 | 769 | 0.040 |
Why?
|
Factor XIII | 1 | 2020 | 58 | 0.040 |
Why?
|
Sweden | 2 | 2016 | 1381 | 0.040 |
Why?
|
Motor Activity | 3 | 2016 | 2704 | 0.040 |
Why?
|
Mifepristone | 1 | 2000 | 150 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2858 | 0.040 |
Why?
|
Prostate | 2 | 2022 | 1755 | 0.040 |
Why?
|
Cross-Sectional Studies | 6 | 2020 | 26313 | 0.040 |
Why?
|
Magnesium | 1 | 2023 | 813 | 0.040 |
Why?
|
Connecticut | 2 | 2011 | 365 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 370 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5696 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2023 | 588 | 0.040 |
Why?
|
Corneal Diseases | 1 | 2005 | 535 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2277 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2011 | 247 | 0.040 |
Why?
|
GTP-Binding Proteins | 2 | 2014 | 944 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2020 | 103 | 0.040 |
Why?
|
Beer | 1 | 2019 | 134 | 0.040 |
Why?
|
Caspase 8 | 1 | 2019 | 198 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 65189 | 0.040 |
Why?
|
Group VI Phospholipases A2 | 1 | 2018 | 16 | 0.040 |
Why?
|
Food | 2 | 2016 | 764 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2020 | 149 | 0.040 |
Why?
|
Sleep | 1 | 2014 | 4812 | 0.040 |
Why?
|
Wine | 1 | 2019 | 172 | 0.040 |
Why?
|
DNA Repair Enzymes | 2 | 2012 | 342 | 0.040 |
Why?
|
Germany | 1 | 2021 | 882 | 0.040 |
Why?
|
Fetal Diseases | 1 | 2004 | 914 | 0.040 |
Why?
|
Prevalence | 5 | 2016 | 15839 | 0.040 |
Why?
|
Tonometry, Ocular | 1 | 2019 | 238 | 0.040 |
Why?
|
DNA Mutational Analysis | 3 | 2017 | 4108 | 0.040 |
Why?
|
Stem Cell Factor | 1 | 2018 | 194 | 0.040 |
Why?
|
Diglycerides | 1 | 2018 | 174 | 0.040 |
Why?
|
Women | 1 | 2020 | 226 | 0.040 |
Why?
|
Hypoxanthine | 1 | 2018 | 28 | 0.040 |
Why?
|
Cell Transplantation | 1 | 2000 | 473 | 0.040 |
Why?
|
Comorbidity | 3 | 2023 | 10563 | 0.040 |
Why?
|
Weight Gain | 1 | 2008 | 2355 | 0.040 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2017 | 18 | 0.040 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 245 | 0.040 |
Why?
|
Educational Status | 2 | 2016 | 2513 | 0.040 |
Why?
|
Phospholipase C beta | 1 | 2017 | 48 | 0.040 |
Why?
|
Cause of Death | 2 | 2021 | 3708 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2018 | 122 | 0.040 |
Why?
|
Fasting | 2 | 2017 | 1606 | 0.040 |
Why?
|
Trans-Activators | 2 | 2008 | 2850 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4850 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 680 | 0.040 |
Why?
|
Disease-Free Survival | 4 | 2015 | 6832 | 0.040 |
Why?
|
Synaptophysin | 1 | 2017 | 137 | 0.040 |
Why?
|
Vocabulary | 1 | 2018 | 165 | 0.040 |
Why?
|
Tea | 1 | 2019 | 290 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1146 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2018 | 126 | 0.040 |
Why?
|
Ovarian Follicle | 1 | 2019 | 243 | 0.040 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2017 | 122 | 0.040 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 130 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1325 | 0.040 |
Why?
|
Calcifediol | 1 | 2018 | 156 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2009 | 533 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 272 | 0.040 |
Why?
|
Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
Lymphokines | 1 | 2000 | 911 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2000 | 624 | 0.030 |
Why?
|
Receptors, Cell Surface | 2 | 2020 | 2817 | 0.030 |
Why?
|
Inosine | 1 | 2018 | 129 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2016 | 1151 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.030 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 1998 | 166 | 0.030 |
Why?
|
Workflow | 1 | 2022 | 862 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1999 | 0.030 |
Why?
|
Amidohydrolases | 1 | 2018 | 162 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2016 | 6 | 0.030 |
Why?
|
Microvascular Angina | 1 | 1996 | 14 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 2019 | 327 | 0.030 |
Why?
|
Base Sequence | 3 | 2019 | 12403 | 0.030 |
Why?
|
Sweetening Agents | 1 | 2019 | 291 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2019 | 81515 | 0.030 |
Why?
|
Canada | 1 | 2022 | 2119 | 0.030 |
Why?
|
Cyclophilins | 1 | 2016 | 47 | 0.030 |
Why?
|
Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
Sudan | 1 | 2016 | 86 | 0.030 |
Why?
|
tRNA Methyltransferases | 1 | 2016 | 50 | 0.030 |
Why?
|
RNA-Binding Proteins | 2 | 2018 | 1874 | 0.030 |
Why?
|
Cell Adhesion Molecules | 2 | 2015 | 1612 | 0.030 |
Why?
|
Histones | 2 | 2017 | 2584 | 0.030 |
Why?
|
Factor Analysis, Statistical | 2 | 2012 | 999 | 0.030 |
Why?
|
Simvastatin | 1 | 2018 | 345 | 0.030 |
Why?
|
Disease Models, Animal | 4 | 2017 | 18294 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 3421 | 0.030 |
Why?
|
Oxidative Stress | 3 | 2015 | 3141 | 0.030 |
Why?
|
Asia | 1 | 2017 | 628 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8728 | 0.030 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2020 | 479 | 0.030 |
Why?
|
Porphyrins | 1 | 2018 | 351 | 0.030 |
Why?
|
Oncogene Proteins v-myb | 1 | 2015 | 26 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
Child, Preschool | 6 | 2016 | 42500 | 0.030 |
Why?
|
Muscles | 1 | 2000 | 1578 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2017 | 328 | 0.030 |
Why?
|
Translocation, Genetic | 2 | 1998 | 1394 | 0.030 |
Why?
|
Gene Transfer Techniques | 1 | 2000 | 1216 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10729 | 0.030 |
Why?
|
Lymphocytes | 1 | 2003 | 2599 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2016 | 14447 | 0.030 |
Why?
|
Blood Cell Count | 1 | 2016 | 405 | 0.030 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2014 | 32 | 0.030 |
Why?
|
Alcoholism | 1 | 2005 | 1975 | 0.030 |
Why?
|
Phosphorylation | 2 | 2017 | 8278 | 0.030 |
Why?
|
Tissue Culture Techniques | 1 | 2016 | 286 | 0.030 |
Why?
|
Coffee | 1 | 2019 | 593 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 247 | 0.030 |
Why?
|
Myoblasts | 1 | 2015 | 234 | 0.030 |
Why?
|
Smell | 1 | 2016 | 259 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1745 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2015 | 212 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 17594 | 0.030 |
Why?
|
Finland | 1 | 2016 | 608 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
Purines | 1 | 2018 | 615 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2001 | 1727 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 245 | 0.030 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 371 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2017 | 592 | 0.030 |
Why?
|
Lung Volume Measurements | 1 | 2015 | 381 | 0.030 |
Why?
|
Dynamin II | 1 | 2014 | 35 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2018 | 708 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 2014 | 56 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 56 | 0.030 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2659 | 0.030 |
Why?
|
Receptor, Endothelin B | 1 | 2014 | 46 | 0.030 |
Why?
|
Chromatin | 2 | 2018 | 2980 | 0.030 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2014 | 89 | 0.030 |
Why?
|
Mathematical Computing | 1 | 2014 | 143 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
Child Mortality | 1 | 2016 | 204 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 369 | 0.030 |
Why?
|
ets-Domain Protein Elk-4 | 1 | 2013 | 5 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2014 | 238 | 0.030 |
Why?
|
Maternal Age | 1 | 2016 | 804 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 618 | 0.030 |
Why?
|
Public Policy | 1 | 1998 | 551 | 0.030 |
Why?
|
Liver | 3 | 2018 | 7562 | 0.030 |
Why?
|
Silencer Elements, Transcriptional | 1 | 2013 | 10 | 0.030 |
Why?
|
Eye Color | 1 | 2013 | 35 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2033 | 0.030 |
Why?
|
Denmark | 1 | 2016 | 774 | 0.030 |
Why?
|
Vitamins | 2 | 2012 | 1630 | 0.030 |
Why?
|
Dynamins | 1 | 2014 | 138 | 0.030 |
Why?
|
Mothers | 1 | 2004 | 2208 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1053 | 0.030 |
Why?
|
Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
Eye | 1 | 2017 | 710 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1742 | 0.030 |
Why?
|
Intelligence | 1 | 2018 | 923 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2000 | 1375 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2015 | 784 | 0.030 |
Why?
|
Xanthophylls | 1 | 2012 | 95 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 2016 | 453 | 0.030 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4778 | 0.030 |
Why?
|
Angiogenic Proteins | 1 | 2013 | 101 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 1740 | 0.030 |
Why?
|
Neuromyelitis Optica | 1 | 2016 | 266 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2013 | 295 | 0.030 |
Why?
|
Nails | 1 | 2014 | 298 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2017 | 762 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 2012 | 190 | 0.020 |
Why?
|
Lutein | 1 | 2012 | 123 | 0.020 |
Why?
|
Trichomonas vaginalis | 1 | 2012 | 70 | 0.020 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 163 | 0.020 |
Why?
|
Inhibins | 1 | 2012 | 211 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 3685 | 0.020 |
Why?
|
Vegetables | 1 | 2017 | 1200 | 0.020 |
Why?
|
Alcohol Dehydrogenase | 1 | 2012 | 113 | 0.020 |
Why?
|
Mexico | 1 | 2014 | 777 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1119 | 0.020 |
Why?
|
Exons | 2 | 2008 | 2391 | 0.020 |
Why?
|
SOX9 Transcription Factor | 1 | 2012 | 146 | 0.020 |
Why?
|
Piperidines | 1 | 2000 | 1664 | 0.020 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2012 | 145 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 323 | 0.020 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2012 | 146 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 746 | 0.020 |
Why?
|
Hemoglobins | 1 | 2018 | 1530 | 0.020 |
Why?
|
Exosomes | 1 | 2016 | 421 | 0.020 |
Why?
|
Calibration | 1 | 2014 | 814 | 0.020 |
Why?
|
Reaction Time | 1 | 2018 | 2086 | 0.020 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5389 | 0.020 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2011 | 30 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2018 | 1003 | 0.020 |
Why?
|
Thymidylate Synthase | 1 | 2011 | 73 | 0.020 |
Why?
|
Pakistan | 1 | 2012 | 300 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1965 | 0.020 |
Why?
|
DNA Primase | 1 | 2012 | 110 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2476 | 0.020 |
Why?
|
Work | 1 | 2012 | 195 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1599 | 0.020 |
Why?
|
Luciferases | 1 | 2013 | 713 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 368 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2012 | 404 | 0.020 |
Why?
|
beta Carotene | 1 | 2012 | 522 | 0.020 |
Why?
|
Androgens | 2 | 2011 | 1279 | 0.020 |
Why?
|
Models, Animal | 1 | 2017 | 2120 | 0.020 |
Why?
|
Progestins | 1 | 2013 | 300 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2014 | 707 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 1992 | 493 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2009 | 5197 | 0.020 |
Why?
|
Life Change Events | 1 | 2016 | 954 | 0.020 |
Why?
|
Religion | 1 | 2014 | 376 | 0.020 |
Why?
|
Benzyl Compounds | 2 | 1980 | 19 | 0.020 |
Why?
|
Exodeoxyribonucleases | 1 | 2012 | 191 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3089 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 1 | 2010 | 47 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 595 | 0.020 |
Why?
|
Sex Chromosome Aberrations | 1 | 2010 | 116 | 0.020 |
Why?
|
Boron Compounds | 1 | 2012 | 196 | 0.020 |
Why?
|
Dual-Specificity Phosphatases | 1 | 2010 | 71 | 0.020 |
Why?
|
Pigmentation | 1 | 2011 | 143 | 0.020 |
Why?
|
Research Report | 1 | 2013 | 367 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 152 | 0.020 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2012 | 340 | 0.020 |
Why?
|
Gene Deletion | 2 | 2009 | 2666 | 0.020 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2010 | 103 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 697 | 0.020 |
Why?
|
Glycosyltransferases | 1 | 2010 | 114 | 0.020 |
Why?
|
Piperazines | 1 | 2000 | 2549 | 0.020 |
Why?
|
Cyprus | 1 | 2010 | 96 | 0.020 |
Why?
|
Somatomedins | 1 | 2010 | 177 | 0.020 |
Why?
|
Samoa | 1 | 2009 | 5 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1123 | 0.020 |
Why?
|
Metabolic Clearance Rate | 2 | 1980 | 360 | 0.020 |
Why?
|
Integrin beta Chains | 1 | 2010 | 116 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3837 | 0.020 |
Why?
|
Caspase 10 | 1 | 2009 | 3 | 0.020 |
Why?
|
Cell Cycle Proteins | 2 | 2015 | 3430 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2035 | 0.020 |
Why?
|
Glucose | 2 | 2012 | 4335 | 0.020 |
Why?
|
Lymphoma, T-Cell | 1 | 1992 | 309 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 990 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2010 | 187 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1072 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2010 | 175 | 0.020 |
Why?
|
Neuroblastoma | 1 | 2017 | 1263 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 2015 | 1349 | 0.020 |
Why?
|
North America | 1 | 2013 | 1285 | 0.020 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2009 | 75 | 0.020 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 88 | 0.020 |
Why?
|
Adolescent Development | 1 | 2012 | 275 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2014 | 1731 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2012 | 1180 | 0.020 |
Why?
|
Integrins | 1 | 2013 | 840 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2011 | 222 | 0.020 |
Why?
|
Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2017 | 1889 | 0.020 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2012 | 482 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1998 | 1560 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1525 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3067 | 0.020 |
Why?
|
Hyperthermia, Induced | 1 | 1992 | 415 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 207 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2739 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2014 | 1154 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2008 | 56 | 0.020 |
Why?
|
Interleukin-16 | 1 | 2008 | 34 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 507 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1992 | 791 | 0.020 |
Why?
|
Education | 1 | 2011 | 533 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4015 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2011 | 791 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2009 | 423 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5077 | 0.020 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 390 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2009 | 4348 | 0.020 |
Why?
|
Chromatography, Gas | 1 | 2007 | 151 | 0.020 |
Why?
|
Reference Standards | 1 | 2011 | 1013 | 0.020 |
Why?
|
Thrombophilia | 1 | 2010 | 308 | 0.020 |
Why?
|
Heart Conduction System | 1 | 2013 | 1006 | 0.020 |
Why?
|
Calcium Channels, T-Type | 1 | 2007 | 28 | 0.020 |
Why?
|
Betaine-Homocysteine S-Methyltransferase | 1 | 2007 | 6 | 0.020 |
Why?
|
Ferredoxin-NADP Reductase | 1 | 2007 | 12 | 0.020 |
Why?
|
India | 1 | 2014 | 2334 | 0.020 |
Why?
|
Transcobalamins | 1 | 2007 | 22 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 2942 | 0.020 |
Why?
|
Nicotine | 1 | 2012 | 682 | 0.020 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 58 | 0.020 |
Why?
|
Infant | 4 | 2016 | 36385 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15543 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2001 | 5343 | 0.020 |
Why?
|
Oxidoreductases | 1 | 2009 | 409 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2007 | 238 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2008 | 265 | 0.020 |
Why?
|
Social Class | 1 | 2016 | 2007 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1192 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2825 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4736 | 0.020 |
Why?
|
Substance-Related Disorders | 2 | 2016 | 4415 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2015 | 18973 | 0.020 |
Why?
|
Data Mining | 1 | 2011 | 562 | 0.020 |
Why?
|
Aneuploidy | 1 | 2010 | 578 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 499 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1761 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 852 | 0.020 |
Why?
|
Health Occupations | 1 | 2008 | 226 | 0.020 |
Why?
|
Databases, Factual | 2 | 2014 | 8067 | 0.020 |
Why?
|
Lipolysis | 1 | 2007 | 211 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2009 | 633 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 658 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 1997 | 7836 | 0.020 |
Why?
|
Seasons | 1 | 2012 | 1524 | 0.020 |
Why?
|
New Hampshire | 1 | 2006 | 174 | 0.020 |
Why?
|
Karyotyping | 2 | 1998 | 1178 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2011 | 12437 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4562 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2007 | 271 | 0.020 |
Why?
|
DNA Damage | 1 | 2015 | 2457 | 0.020 |
Why?
|
Health Care Costs | 1 | 2019 | 3242 | 0.020 |
Why?
|
Herpesvirus 4, Human | 1 | 2011 | 1078 | 0.020 |
Why?
|
Mitochondria | 1 | 2019 | 3673 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
Los Angeles | 1 | 2006 | 244 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2007 | 358 | 0.020 |
Why?
|
Color | 1 | 2006 | 299 | 0.020 |
Why?
|
Reference Values | 1 | 2012 | 4908 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 932 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5881 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7122 | 0.020 |
Why?
|
Sex Distribution | 1 | 2010 | 2263 | 0.010 |
Why?
|
Sunburn | 1 | 2006 | 156 | 0.010 |
Why?
|
Eicosapentaenoic Acid | 1 | 2009 | 565 | 0.010 |
Why?
|
Dietary Fiber | 1 | 2009 | 767 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5501 | 0.010 |
Why?
|
Spermatogenesis | 1 | 2006 | 260 | 0.010 |
Why?
|
Sunlight | 1 | 2006 | 337 | 0.010 |
Why?
|
Diet Surveys | 1 | 2008 | 1159 | 0.010 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 904 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1394 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2845 | 0.010 |
Why?
|
Anthropometry | 1 | 2008 | 1338 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2003 | 41 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7425 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2009 | 869 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6919 | 0.010 |
Why?
|
Ataxia Telangiectasia | 1 | 2004 | 107 | 0.010 |
Why?
|
Adult Children | 1 | 2003 | 104 | 0.010 |
Why?
|
Cadherins | 1 | 2008 | 900 | 0.010 |
Why?
|
Leucine | 1 | 2004 | 546 | 0.010 |
Why?
|
Dust | 1 | 2006 | 489 | 0.010 |
Why?
|
Immunophenotyping | 2 | 1998 | 1866 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2966 | 0.010 |
Why?
|
Information Dissemination | 1 | 2011 | 1142 | 0.010 |
Why?
|
Hair | 1 | 2006 | 508 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2005 | 602 | 0.010 |
Why?
|
Nitrogen Dioxide | 1 | 2006 | 538 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4489 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 1995 | 0.010 |
Why?
|
Carbon Monoxide | 1 | 2006 | 560 | 0.010 |
Why?
|
Dosage Compensation, Genetic | 1 | 2003 | 209 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1167 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2014 | 2067 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11022 | 0.010 |
Why?
|
New England | 1 | 2005 | 1059 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3458 | 0.010 |
Why?
|
Health Behavior | 1 | 2013 | 2650 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9373 | 0.010 |
Why?
|
Emotions | 1 | 2013 | 2763 | 0.010 |
Why?
|
Adipocytes | 1 | 2008 | 1194 | 0.010 |
Why?
|
Autoantibodies | 1 | 2010 | 2113 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1996 | 4533 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 1718 | 0.010 |
Why?
|
Ultraviolet Rays | 1 | 2006 | 1102 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3737 | 0.010 |
Why?
|
Levonorgestrel | 1 | 2000 | 76 | 0.010 |
Why?
|
Public Health | 1 | 2013 | 2680 | 0.010 |
Why?
|
Lac Operon | 1 | 2000 | 238 | 0.010 |
Why?
|
Densitometry | 1 | 1980 | 150 | 0.010 |
Why?
|
Rats | 3 | 1981 | 23707 | 0.010 |
Why?
|
Ovulation | 1 | 2000 | 178 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2000 | 461 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1981 | 2077 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6493 | 0.010 |
Why?
|
Autoradiography | 1 | 1980 | 723 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6113 | 0.010 |
Why?
|
Environmental Monitoring | 1 | 2006 | 1470 | 0.010 |
Why?
|
Drug Compounding | 1 | 2000 | 235 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2009 | 2054 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3106 | 0.010 |
Why?
|
Pyridazines | 1 | 2000 | 200 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2008 | 2446 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6851 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2005 | 1481 | 0.010 |
Why?
|
Overweight | 1 | 2010 | 2443 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1992 | 3310 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 682 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 2000 | 308 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 754 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 2000 | 907 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9338 | 0.010 |
Why?
|
Endometrium | 1 | 2000 | 406 | 0.010 |
Why?
|
Life Tables | 1 | 1998 | 363 | 0.010 |
Why?
|
Cytogenetics | 1 | 1998 | 198 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2000 | 854 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1752 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1980 | 2266 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8871 | 0.010 |
Why?
|
Brain | 2 | 2016 | 27178 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2001 | 804 | 0.010 |
Why?
|
Myocardium | 1 | 2008 | 4760 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1998 | 498 | 0.010 |
Why?
|
Mice, SCID | 1 | 2000 | 2630 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5337 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 4734 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15880 | 0.010 |
Why?
|
Critical Care | 1 | 2007 | 2712 | 0.010 |
Why?
|
Feces | 1 | 1980 | 1504 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11640 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5772 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4475 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 283 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2000 | 2844 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36532 | 0.010 |
Why?
|
Protein Binding | 1 | 2000 | 9296 | 0.000 |
Why?
|
Myocardial Ischemia | 1 | 1996 | 2128 | 0.000 |
Why?
|
Hot Temperature | 1 | 1992 | 1433 | 0.000 |
Why?
|
Kidney | 1 | 1980 | 7066 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1992 | 4860 | 0.000 |
Why?
|
Graft Rejection | 1 | 1992 | 4499 | 0.000 |
Why?
|